Complete Phase Consulting

Executive Summary

Complete Phase Consulting is a founder-led CRO based in Melbourne, Australia, specializing in early-phase (Phase I-II) clinical trials across oncology, immunology, and CNS therapeutics. With a lean team of senior experts, the company offers transparent, end-to-end services including trial strategy, project management, monitoring, regulatory affairs, and pharmacovigilance. Founded in 2020, it serves biotech and global CROs, leveraging its Australian base to provide cost-effective, high-quality trial execution. The company's expertise in complex therapeutic areas positions it well to capture growing demand from sponsors seeking efficient early-phase development partners. As a private services firm, its growth is driven by client wins and project volume rather than external funding, making it a resilient player in the CRO space.

Upcoming Catalysts (preview)

• Q3 2026Strategic Partnership with a Global CRO for Late-Stage Referrals70% success
• Q1 2027Expansion into Gene Therapy and Rare Disease Trials50% success
• Q2 2026Award of Multiple New Contracts from Mid-Size Biotechs80% success